D.E. Shaw & Co’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,075
| Closed | -$619K | – | 3357 |
|
|
2023
Q2 | $619K | Sell |
6,075
-87,341
| -93% | -$8.91M | ﹤0.01% | 2265 |
|
|
2023
Q1 | $8.49M | Sell |
93,416
-228,467
| -71% | -$20.8M | 0.01% | 1033 |
|
|
2022
Q4 | $12.2M | Buy |
321,883
+156,053
| +94% | +$5.93M | 0.01% | 858 |
|
|
2022
Q3 | $4.17M | Sell |
165,830
-93,825
| -36% | -$2.36M | 0.01% | 1613 |
|
|
2022
Q2 | $7.89M | Buy |
259,655
+203,765
| +365% | +$6.19M | 0.01% | 1167 |
|
|
2022
Q1 | $1.83M | Buy |
55,890
+7,761
| +16% | +$254K | ﹤0.01% | 2493 |
|
|
2021
Q4 | $1.27M | Buy |
+48,129
| New | +$1.27M | ﹤0.01% | 2624 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3963 |
|
|
2020
Q4 | – | Sell |
-5,720
| Closed | -$557K | – | 2939 |
|
|
2020
Q3 | $557K | Sell |
5,720
-16,125
| -74% | -$1.57M | ﹤0.01% | 2079 |
|
|
2020
Q2 | $3.41M | Buy |
21,845
+19,080
| +690% | +$2.98M | ﹤0.01% | 1362 |
|
|
2020
Q1 | $399K | Buy |
+2,765
| New | +$399K | ﹤0.01% | 2229 |
|
|
2019
Q4 | – | Sell |
-4,300
| Closed | -$345K | – | 2856 |
|
|
2019
Q3 | $345K | Buy |
+4,300
| New | +$345K | ﹤0.01% | 2217 |
|
|
2019
Q2 | – | Sell |
-24,329
| Closed | -$2.08M | – | 2789 |
|
|
2019
Q1 | $2.08M | Buy |
24,329
+5,133
| +27% | +$439K | ﹤0.01% | 1550 |
|
|
2018
Q4 | $1.08M | Sell |
19,196
-26,823
| -58% | -$1.5M | ﹤0.01% | 1814 |
|
|
2018
Q3 | $3.76M | Buy |
+46,019
| New | +$3.76M | ﹤0.01% | 1244 |
|